Name | nardosinone |
---|---|
Synonyms |
Nardosinone
5H-Naphtho[2,1-c][1,2]dioxol-5-one, 1,3a,4,7,8,9,9a,9b-octahydro-1,1,9,9a-tetramethyl-, (3aR,9R,9aR,9bS)- 5H-Naphtho[2,1-c][1,2]dioxol-5-one,1,3a,4,7,8,9,9a,9b-octahydro-1,1,9,9a-tetramethyl-, (3aR,9R,9aR,9bS)- (3aR,9R,9aR,9bS)-1,1,9,9a-Tetramethyl-1,3a,4,7,8,9,9a,9b-octahydro-5H-naphtho[2,1-c][1,2]dioxol-5-one |
Description | Nardosinone, isolated from Nardostachys chinensis, is the first enhancer of the neuritogenic action of dbcAMP and staurosporine. Nardosinone may become a useful pharmacological tool for studying the mechanism of action of not only nerve growth factor (NGF) but also both the neuritogenic substances[1]. |
---|---|
Related Catalog | |
In Vitro | Nardosinone (0.1-100 microM) enhanced dibutyryl cyclic AMP (dbcAMP, 0.3 mM)- and staurosporine (10 nM)-induced neurite outgrowth from PC12D cells in a concentration-dependent manner. Nardosinone enhances a downstream step of MAP kinase in the MAP kinase-dependent signaling pathway[1]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 330.2±32.0 °C at 760 mmHg |
Melting Point | 108-110℃ |
Molecular Formula | C15H22O3 |
Molecular Weight | 250.333 |
Flash Point | 142.0±25.2 °C |
Exact Mass | 250.156891 |
PSA | 35.53000 |
LogP | 3.04 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.522 |
Storage condition | 2-8C |
HS Code | 29145090 |
---|
~50% 23720-80-1 |
Literature: Archiv der Pharmazie, , vol. 323, # 3 p. 171 - 175 |
~4% 23720-80-1
Detail
|
Literature: Archiv der Pharmazie, , vol. 323, # 3 p. 171 - 175 |
~50% 23720-80-1 |
Literature: Ruecker, Gerhard; Olbrich, Armin Tetrahedron Letters, 1988 , vol. 29, # 37 p. 4703 - 4704 |
~% 23720-80-1
Detail
|
Literature: Archiv der Pharmazie, , vol. 323, # 3 p. 171 - 175 |
Precursor 1 | |
---|---|
DownStream 0 |